These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34987434)

  • 21. Neuropsychiatric symptoms in older people with and without cognitive impairment.
    Brodaty H; Heffernan M; Draper B; Reppermund S; Kochan NA; Slavin MJ; Trollor JN; Sachdev PS
    J Alzheimers Dis; 2012; 31(2):411-20. PubMed ID: 22571979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anxiety, Depression, and Apathy as Predictors of Cognitive Decline in Patients With Parkinson's Disease-A Three-Year Follow-Up Study.
    Toloraia K; Meyer A; Beltrani S; Fuhr P; Lieb R; Gschwandtner U
    Front Neurol; 2022; 13():792830. PubMed ID: 35211081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apathy secondary to stroke: a systematic review and meta-analysis.
    Caeiro L; Ferro JM; Costa J
    Cerebrovasc Dis; 2013; 35(1):23-39. PubMed ID: 23428994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study.
    Geda YE; Roberts RO; Knopman DS; Petersen RC; Christianson TJ; Pankratz VS; Smith GE; Boeve BF; Ivnik RJ; Tangalos EG; Rocca WA
    Arch Gen Psychiatry; 2008 Oct; 65(10):1193-8. PubMed ID: 18838636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis.
    Martin GP; McDonald KR; Allsop D; Diggle PJ; Leroi I
    J Neurol; 2020 Jan; 267(1):214-227. PubMed ID: 31616991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-pharmacological Approaches to Apathy and Depression: A Scoping Review of Mild Cognitive Impairment and Dementia.
    Oba H; Kobayashi R; Kawakatsu S; Suzuki K; Otani K; Ihara K
    Front Psychol; 2022; 13():815913. PubMed ID: 35250746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Apathy, depression and cognitive functioning in patients with MCI and dementia].
    Vloeberghs R; Opmeer EM; De Deyn PP; Engelborghs S; De Roeck EE
    Tijdschr Gerontol Geriatr; 2018 Jun; 49(3):95-102. PubMed ID: 29488192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body mass index and mild cognitive impairment-to-dementia progression in 24 months: a prospective study.
    Sobów T; Fendler W; Magierski R
    Eur J Clin Nutr; 2014 Nov; 68(11):1216-9. PubMed ID: 25117990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychiatric Disturbances in Mild Cognitive Impairment (MCI): A Systematic Review of Population-Based Studies.
    Köhler CA; Magalhaes TF; Oliveira JM; Alves GS; Knochel C; Oertel-Knöchel V; Pantel J; Carvalho AF
    Curr Alzheimer Res; 2016; 13(10):1066-82. PubMed ID: 27137220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Emergence of Neuropsychiatric Symptoms in Cognitively Normal Subjects and Mild Cognitive Impairment.
    Tsunoda K; Yamashita T; Osakada Y; Sasaki R; Tadokoro K; Matsumoto N; Nomura E; Morihara R; Nakano Y; Takahashi Y; Hatanaka N; Shang J; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    J Alzheimers Dis; 2020; 73(1):209-215. PubMed ID: 31771056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia.
    Leoutsakos JM; Forrester SN; Lyketsos CG; Smith GS
    J Alzheimers Dis; 2015; 48(2):483-93. PubMed ID: 26402012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.
    Ng TP; Feng L; Nyunt MS; Feng L; Gao Q; Lim ML; Collinson SL; Chong MS; Lim WS; Lee TS; Yap P; Yap KB
    JAMA Neurol; 2016 Apr; 73(4):456-63. PubMed ID: 26926205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the neuropsychiatric inventory predict progression from mild cognitive impairment to dementia? A systematic review and meta-analysis.
    Mallo SC; Patten SB; Ismail Z; Pereiro AX; Facal D; Otero C; Juncos-Rabadán O
    Ageing Res Rev; 2020 Mar; 58():101004. PubMed ID: 31881368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.
    Palmer K; Di Iulio F; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Spalletta G
    J Alzheimers Dis; 2010; 20(1):175-83. PubMed ID: 20164594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.
    Mielke MM; Hagen CE; Wennberg AMV; Airey DC; Savica R; Knopman DS; Machulda MM; Roberts RO; Jack CR; Petersen RC; Dage JL
    JAMA Neurol; 2017 Sep; 74(9):1073-1080. PubMed ID: 28692710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.
    Di Carlo A; Baldereschi M; Lamassa M; Bovis F; Inzitari M; Solfrizzi V; Panza F; Galluzzo L; Scafato E; Inzitari D;
    J Alzheimers Dis; 2016 May; 53(2):505-15. PubMed ID: 27163817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
    Lyketsos CG; Lopez O; Jones B; Fitzpatrick AL; Breitner J; DeKosky S
    JAMA; 2002 Sep; 288(12):1475-83. PubMed ID: 12243634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depressive Symptoms in Mild Cognitive Impairment and the Risk of Dementia: A Systematic Review and Comparative Meta-Analysis of Clinical and Community-Based Studies.
    Tan EYL; Köhler S; Hamel REG; Muñoz-Sánchez JL; Verhey FRJ; Ramakers IHGB
    J Alzheimers Dis; 2019; 67(4):1319-1329. PubMed ID: 30689564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.